CRT Reiterates On Edwards Lifesciences, Sees 'Many Future Growth Opportunities'

By: via Benzinga
CRT reiterated its Buy rating and $150 price target on Edwards Lifesciences Corp (NYSE: EW) Wednesday following the company’s ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.